{
    "nct_id": "NCT04678115",
    "official_title": "A Randomized Cross-Over Clinical Trial Comparing Two Non-Surgical Treatments for Severe Blepharoptosis",
    "inclusion_criteria": "* Presence of ptosis for at least one eye which occludes the visual axis in the resting position (without frontalis drive, lifting with forehead muscles)\n* Moderate cognitive function or better defined as greater than or equal to 18 out of 30 on a pre-screening of the Mini-Mental State Exam (MMSE)\nHealthy volunteers allowed\nMust have minimum age of 5 Years",
    "exclusion_criteria": "* Absence of ptosis which occludes the visual axis\n* Presence of a corneal ulcer of any size\n* Age less than 5 years\n* Severe Cognitive impairment defined as MMSE score less than 18, behaviors consistent with delirium (combinations of disorientation, hallucinations, delusions, and incoherent speech), or lethargy.\n* Presence of corneal hypoaesthesia;\n* Orbicularis weakness on the side of the ptosis\n* Mechanical ptosis, including ptosis due to orbital or lid tumor, cicatricial processes affecting the movements of the upper lid, and enophthalmos.\n* Previous ptosis surgery less than 3 months prior to Visit 1.\n* Lid position affected by lid or conjunctival scarring.\n* History of herpes keratitis.\n* Periocular neurotoxin (eg, Botox, Xeomin, Dysport, Myobloc) injections on the side of the ptosis within 3 months prior to Visit 1 and during the study.\n* History of hyperthyroidism or thyroid eye disease (ie, exophthalmos, upper eyelid retraction, diplopia secondary to extraocular muscle involvement). Hypothyroidism that is controlled on medication is allowed",
    "miscellaneous_criteria": ""
}